| Code | 3192B | ||||||||||
| MA number | 69/0071/15-S | ||||||||||
| Product Form: | aer ors 1x150 dávok (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | BAUSCH HEALTH IRELAND LIMITED, Ireland | ||||||||||
| Therapeutic Class: | 69 - OTORHINOLARYNGOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | bottle HDPE with dose dispenser | ||||||||||
| Route of admin.: | Oropharyngeal use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 25.02.2015 |
| Pediatric posology: | Yes |
| PIL: |
PIL_Garganta 1,5 mg/ml_09/2024.pdf
|
| SPC: |
SPC_Garganta 1,5 mg/ml_09/2024.pdf
|
| Safety feature | No |
| Data update: | 04.03.2020 |
